Similar content being viewed by others 1 Introduction GLP-1 is an endogenous incretin hormone produced by intestinal L-cells that modulates postprandial glucose levels via glucose-dependent insulin production, offering intrinsic protection against hypoglycemia (Zander et al
This review aims to provide practical guidance on CGM implementation in clinical practice, examining features of currently available CGM devices, clinical evidence, benefits, and real-world challenges associated with CGM
Services explicitly covered include Botox and dermal fillers, weight-loss therapies, hormone treatments, hair-loss services and parenteral nutrient infusions
such tests ensure high sensitivity of measurement, both in terms of accuracy and speed of performance across various cognitive domains
Researchers have long been interested in the connections between these conditions and in how pharmacological treatments may affect both metabolic and mental health disorders